Table: Shin Nippon Biomedical - 6-MTH group results

Shin Nippon Biomedical Laboratories

07/11/2025 24:00

Nov 7 (Reuters)- 
             Shin Nippon Biomedical Laboratories Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2025        Sep 30, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             14.77               12.51            33.27    
                 (+18.1 pct)         (+5.3 pct)       (+2.6 pct)  
  Operating        49 mln              80 mln             3.55    
                 (-38.4 pct)         (-96.6 pct)      (+18.9 pct) 
  Recurring          1.63                1.83             5.93    
                 (-11.0 pct)         (-51.3 pct)      (-8.1 pct)  
  Net                1.06                1.33             3.55    
                 (-20.3 pct)         (-55.1 pct)      (-27.9 pct) 
  EPS             25.48 yen           31.97 yen        85.27 yen  
  Ann Div                             50.00 yen        50.00 yen  
  -Q2 div         20.00 yen           20.00 yen                   
  -Q4 div                             30.00 yen        30.00 yen  
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T